- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Neuroendocrine Tumors in United States
Total 12864 results
-
PfizerCompletedMelanoma and Metastatic Colorectal CancerUnited States, Spain, France, Japan, Australia, Switzerland, Norway
-
Clinigen, Inc.Johns Hopkins University; M.D. Anderson Cancer CenterTerminatedMetastatic MelanomaUnited States
-
PfizerCompletedBRAF or NRAS Mutant Metastatic MelanomaUnited States, Netherlands, Italy, Germany, Switzerland
-
Infinity Pharmaceuticals, Inc.TerminatedMetastatic MelanomaUnited States
-
National Cancer Institute (NCI)CompletedMelanoma | Neoplasm MetastasisUnited States
-
Exicure, Inc.TerminatedAdvanced or Metastatic Solid Tumors | Advanced or Metastatic Merkel Cell Carcinoma | Advanced or Metastatic Cutaneous Squamous Cell Carcinoma | Advanced or Metastatic Melanoma | Advanced or Metastatic Head and Neck Squamous Cell CarcinomaUnited States
-
Reata, a wholly owned subsidiary of BiogenCompletedMelanoma | Unresectable (Stage III) Melanoma | Metastatic (Stage IV) MelanomaUnited States
-
Roshni DasguptaRecruitingSolid Malignancies | Metastatic Disease | Primary TumorUnited States
-
Regeneron PharmaceuticalsBristol-Myers SquibbActive, not recruitingMelanoma | Metastatic Melanoma | Unresectable Melanoma | Advanced MelanomaUnited States
-
PfizerCompletedLocally Advanced or Metastatic NRAS Mutant MelanomaUnited States, Australia, Germany, Italy, Netherlands
-
David PalmaLondon Health Sciences Centre; Amsterdam University Medical Centre, VUmc Site; British Columbia Cancer - Centre for the North and other collaboratorsActive, not recruitingMetastatic TumorsUnited Kingdom, Canada, Switzerland, Netherlands, Australia
-
Advanced Accelerator ApplicationsActive, not recruitingPheochromocytoma | Paraganglioma | Gastroenteropancreatic Neuroendocrine TumorsUnited States, Spain, France, Poland, United Kingdom
-
Maxim PharmaceuticalsNational Cancer Institute (NCI)UnknownMetastatic Cancer | Melanoma (Skin)United States, Canada, Germany, United Kingdom
-
IDEAYA BiosciencesRecruitingColorectal Cancer | Metastatic Uveal Melanoma | Cutaneous Melanoma | Other Solid TumorsUnited States, Australia, Canada
-
IpsenCompletedGastroenteropancreatic Neuroendocrine TumorUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMetastatic Solid TumorsUnited States, Spain, United Kingdom
-
iOncturaActive, not recruitingMyelofibrosis | NSCLC | Uveal Melanoma | Solid Tumor, Adult | Non-Hodgkin Lymphoma, AdultUnited Kingdom, Italy
-
NeuPharma, Inc.RecruitingLocally Advanced Solid Tumors | Metastatic Solid TumorsUnited States
-
Callisto PharmaceuticalsCompletedNeuroendocrine CarcinomaUnited States
-
Jonsson Comprehensive Cancer CenterMedivation, Inc.; BioMarin Pharmaceutical; Translational Research in OncologyCompletedMetastatic Cancer | Unspecified Adult Solid TumorUnited States
-
British Columbia Cancer AgencyThe Alfred; London Regional Cancer Program, Canada; Tom Baker Cancer Centre; Cancer... and other collaboratorsRecruitingMetastatic TumorsCanada, Australia, United Kingdom, Ireland
-
Regeneron PharmaceuticalsBristol-Myers SquibbCompletedMelanoma | Metastatic Melanoma | Unresectable Melanoma | Advanced MelanomaUnited States
-
Bristol-Myers SquibbCompletedUnresectable or Metastatic MelanomaUnited States, Germany, Italy, United Kingdom, Canada, Denmark, Netherlands, Spain, Belgium, France, Switzerland, Israel, Austria, Brazil
-
Lawson Health Research InstituteVU University of Amsterdam; London Regional Cancer Program, CanadaActive, not recruitingMetastatic TumorsCanada, Australia, Netherlands, United Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbActive, not recruitingMetastatic Melanoma | Metastasis to BrainUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisTerminatedNeuroendocrine CarcinomaUnited States
-
Erasca, Inc.RecruitingAdvanced or Metastatic NRAS-mutant MelanomaUnited States
-
Dana-Farber Cancer InstituteBiohaven Pharmaceuticals, Inc.TerminatedMelanoma | Metastatic MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterIovance Biotherapeutics, Inc.Active, not recruiting
-
Boehringer IngelheimRecruitingNeuroendocrine NeoplasmsUnited States, Spain, Germany, Japan
-
National Cancer Institute (NCI)TerminatedSkin Cancer | Metastatic MelanomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingMetastatic Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Metastatic Malignant Neoplasm in the Brain | Metastatic Malignant Neoplasm in the Central Nervous SystemUnited States
-
Xencor, Inc.ICON plcCompletedNeuroendocrine Tumor | Gastrointestinal NeoplasmUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Neuroendocrine Carcinoma of the Skin | Stage III Neuroendocrine Carcinoma of the Skin | Stage II Neuroendocrine Carcinoma of the SkinUnited States
-
University of California, San FranciscoMerck Sharp & Dohme LLCCompletedHigh Grade Malignant Neuroendocrine Carcinoma (Diagnosis)United States
-
National Cancer Institute (NCI)CompletedGastrinoma | Glucagonoma | Insulinoma | Metastatic Gastrointestinal Carcinoid Tumor | Pancreatic Polypeptide Tumor | Recurrent Gastrointestinal Carcinoid Tumor | Recurrent Islet Cell Carcinoma | Somatostatinoma | WDHA SyndromeUnited States
-
Nectin Therapeutics LtdMerck Sharp & Dohme LLCRecruitingCancer | Metastatic Cancer | Advanced Solid Tumor | Tumor, Solid | Locally Advanced Solid TumorUnited States, Israel
-
Fox Chase Cancer CenterIncuronSuspendedLocally Advanced or Metastatic MelanomaUnited States
-
National Cancer Institute (NCI)TerminatedSkin Cancer | Metastatic MelanomaUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompleted
-
Immune DesignMerck Sharp & Dohme LLCCompletedMelanoma - Currently Enrolling | Non-small Cell Lung Cancer - Enrollment Completed | Sarcoma - Enrollment CompletedUnited States
-
Abramson Cancer Center at Penn MedicineMerck Sharp & Dohme LLCRecruitingMerkel Cell CarcinomaUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
Immunomic Therapeutics, Inc.Completed
-
Memorial Sloan Kettering Cancer CenterCompletedGastro-enteropancreatic Neuroendocrine Tumor | Secondary Malignant Neoplasm of LiverUnited States
-
Immune DesignCompletedMerkel Cell CarcinomaUnited States
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; ExelixisCompletedNeuroendocrine Tumors | Carcinoid Tumor | Carcinoid Tumor of GI SystemUnited States
-
Clinigen, Inc.Prometheus LaboratoriesTerminatedMetastatic MelanomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingNeuroendocrine Neoplasm | Multiple Endocrine Neoplasia Type 1 | Advanced Carcinoid Tumor | Digestive System Neuroendocrine Neoplasm | Unresectable Carcinoid TumorUnited States
-
OncoSec Medical IncorporatedNational Cancer Institute (NCI)CompletedMerkel Cell CarcinomaUnited States